Sino Biopharmaceutical Limited (01244.HK): Qinhuangdao Haino withdraws civil lawsuit

Smart Financial News APP, Sino Pharm Group (01244.HK) announced that on June 27, 2025, Qingdao Hainuo applied to the court to withdraw the civil lawsuit. The company is pleased to announce that on July 22, 2025, the company received the civil ruling issued by the court on July 18, 2025. According to this ruling, the court has approved Qingdao Hainuo's request to withdraw the civil lawsuit. Qingdao Hainuo will bear the costs related to case acceptance and preservation order (totaling approximately RMB 1.17 million).